Pantherics Incorporated Receives SBIR Funding from the NIH to Advance New Drug Development

Pantherics Incorporated, a UWM startup company received a $255,841 Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute, to advance development of a fundamentally novel anti-inflammatory drug, with… Read More